Author:
Gallego-Escuredo José M.,Lamarca Maria Karuna,Villarroya Joan,Domingo Joan C.,Mateo Ma Gracia,Gutierrez Ma del Mar,Vidal Francesc,Villarroya Francesc,Domingo Pere,Giralt Marta
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. FGF-21 as a novel metabolic regulator;Kharitonenkov;J Clin Invest,2005
2. Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study;Dong;Br J Clin Pharmacol,2015
3. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes;Gaich;Cell Metab,2013
4. Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients;Domingo;AIDS,2010
5. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients;Gallego-Escuredo;J Acquir Immune Defic Syndr,2012
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献